Immunological effects of yeast- and mushroom-derived β-glucans

Journal of Medicinal Food

Volumn 11, Issue 4, 2008, Pages 615-622

  Vetvicka, Vaclav ^a   Vashishta, Aruna ^a   Saraswat Ohri, Sujata ^a   Vetvickova, Jana ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Gene; Glucan; Immunology; Mushrooms; Yeast

Indexed keywords

BETA 1,3 GLUCAN; BETAMUNE; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; MUSHROOM; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; TUMOR CELL; YEAST;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BETA-GLUCANS; CELL LINE; CYTOKINES; FEMALE; HUMANS; LENTINAN; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PHAGOCYTOSIS; PHYTOTHERAPY; SHIITAKE MUSHROOMS; YEASTS;

ANIMALIA; BASIDIOMYCOTA; MUS;

EID: 57349139673     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0588     Document Type: Article

References (33)

1. Benacerraf B, Sebestyen MM: Effect of bacterial endotoxins on the reticuloendothelial system. Fed Proc 1957;16:860-867.
2. Rigi SJ, Di Luzio NR: Identification of a reticuloendothelial stimulating agent in zymosan. Am J Physiol 1961;200:297-300.
3. Di Luzio NR, Williams DL, McNamee RB, Edwards BF, Kitahama A: Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer 1979;24:773-779.
4. Mimura H, Ohno N, Suzuki I, Yadomae T: Purification, antitumor activity, and structural characterization of β-1,3-glucan from Peziza vesiculosa. Chem Pharm Bull 1985;33:5096-5099.
5. Wang Y, Zhang L, Li Y, Hou X, Zeng F: Correlation of structure to antitumor activities of five derivates of a β-glucan from Poria cocos sclerotium. Carbohydr Res 2004;339:2567-2574.
6. + neutrophils and macrophages that produce tumor regression and tumor-free survival. Mol Immunol 2003;40:195-196.
7. Hong F, Hansen RD, Yan J, Allendorf DJ, Baran JT, Ostroff GR, Ross GD: β-glucan functions as an adjuvantMI-KYUNG SUNG, Ph.D. Sookmyung Women's University Seoul, Korea for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cell. Cancer Res 2003;63:9023-9031.
8. Vetvicka V, Holub M: Phagocytic activity of peritoneal and omental macrophages of athymic nude mice. Immunol Invest 1988;17:531-541.
9. Vetvicka V, Terayama K, Mandeville R, Brousseau P, Kournikakis B, Ostroff G: Pilot study: orally-administered yeast β1,3-glucan prophylactically protects against anthrax infection and cancer in mice. J Am Nutr Assoc 2002;5:1-6.
10. Vetvicka V, Yvin J-C: Effects of marine β-glucan on immune reaction. Int Immunopharmacol 2004;4:721-730.
11. Vetvicka V, Vetvickova J: Immunostimulating properties of two different β-glucans isolated from Maitake mushrooms (Grifola frondosa). J Am Nutr Assoc 2005;8:33-39.
12. Yan J, Zong, H, Shen A, Yin X, Liu W, Gu X, Gu J: The β-(1-6)-branched β-(1-3) glucohexaose and its analogues containing an α-(1-3)-linked bond have similar stimulatory effects on the mouse spleen as lentinan. Int Immunopharmacol 2003;2:1861-1871.
13. Yan J, Allendorf DJ, Brandley B: Yeast whole glucan particle (WGP) beta-glucan in conjuction with antitumor monoclonal antibodies to treat cancer. Expert Opin Biol Ther 2005;5:691-702.
14. Abel G, Szollosi J, Chihara G, Fachet J: Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: a flow cytometric study. Int J Immunopharmacol 1989;11:615-621.
15. Vetvicka V, Fornusek L: Polymer microbeads in immunology. Biomaterials 1987;8:341-345.
16. Holub M, Fornusek L, Vetvicka V, Chalupna J: Enhanced phagocytic activity of blood leukocytes in athymic nude mice. J Leukocyte Biol 1984;35:605-615.
17. Holub M, Vetvicka V, Fornusek L, Paluska E: Phagocytic cells of athymic nude mice in fetal life. In: Immune-Deficient Animals in Biomedical Research (Rygaard J, Brunner A, Graem GH, Spang-Thomsen J, eds.). Karger, Basel, 1987, pp. 59-68.
18. Vetvicka V, Fornusek L, Tlaskalova-Hogenova H, Rihova B: Changes in some properties and functions of plasma membranes of macrophages from young, adult and aged mice. Dev Comp Immunol 1982;6:755-766.
19. Hamuro J: Anticancer immunotherapy with perorally effective lentinan. Gan To Kagaku Ryoho 2005;32:1209-1215.
20. Falch BH, Espevik T, Ryan L, Stokke BT: The cytokine stimulating activity of (1-3)-β-D-glucans is dependent on the triple helix conformation. Carbohydr Res 2000;329:587-596.
21. Bleicher P, Mackin W: Betafectin PGG-glucan: a novel carbohydrate immunomodulator with anti-infective properties. J Biotechnol Healthcare 1995;2:207-222.
22. Ross GD, Vetvicka V, Yan J, Xia J, Vetvickova J: Therapeutic intervention with complement and β-glucan in cancer. Immunopharmacology 1999;42:61-74.
23. Vassallo R, Standing JE, Limper AH: Isolated Pneumocystis carinii cell wall glucan invokes lower respiratory tract inflammatory responses. J Immunol 2000;164:3755-3763.
24. Ohmura Y, Matsunaga K, Motokawa I, Sukarai K, Ando T: Protective effects of a protein-bound polysaccharide, PSK, on Candida albicans infection in mice via tumor necrosis factor-α induction. Int Immunopharmacol 2001;1:1797-1811.
25. Vashishta A, Ohri SS, Vetvickova J, Fusek M, Ulrichova J, Vetvicka V: Procathepsin D secreted by HaCaT keratinocyte cells - a novel regulator of keratinocyte growth. Eur J Cell Biol 2007;86:303-313.
26. Fusek M, Vetvickova J, Vetvicka V: Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects. J Interferon Cytokine Res 2007;27:191-199.
27. Xia Y, Vetvicka V, Yan J, Hanikyrova M, Mayadas TN, Ross GD: The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol 1999;162:2281-2290.
28. Kogan G: (1-3,1-6)-β-glucans of yeast and fungi and their biological activity. In: Studies in Natural Products Chemistry (Atta-ur-Rahman A, ed.). Elsevier, Amsterdam, 2000, pp. 107-152.
29. Yan J, Vetvicka V, Xia Y, Coxon A, Carroll MC, Mayadas TN, Ross GD: β-glucan, a "specific" biological response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J Immunol 1999;163:3045-3052.
30. Ravi R, Bedi A: NF-kappaB in cancer - a friend turned foe. Drug Resist Update 2004;7:53-67.
31. Lin R, Bagrodia S, Cerione R, Manor D: A novel Cdc42Hs mutant induces cellular transformation. Curr Biol 1997;7:794-797.
32. Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y, Fan D: Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 2004;315:686-691.
33. Murphy GA, Jillian SA, Michaelson D, Philips MR, D'Eustachio P, Rush MG: Signaling mediated by the closely related mammalian Rho family GTPases TC10 and Cdc42 suggests distinct functional pathways. Cell Growth Differ 2001;12:157-167.